IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-37872-4.html
   My bibliography  Save this article

CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy

Author

Listed:
  • Yun Chang

    (Purdue University
    Purdue University Institute for Cancer Research)

  • Xuechao Cai

    (Tongji University Cancer Center, Shanghai Tenth People’s Hospital, Tongji University School of Medicine)

  • Ramizah Syahirah

    (Purdue University)

  • Yuxing Yao

    (California Institute of Technology)

  • Yang Xu

    (The Ohio State University)

  • Gyuhyung Jin

    (Purdue University
    Purdue University Institute for Cancer Research)

  • Vijesh J. Bhute

    (Imperial College London, South Kensington Campus)

  • Sandra Torregrosa-Allen

    (Purdue University Institute for Cancer Research)

  • Bennett D. Elzey

    (Purdue University Institute for Cancer Research
    Purdue University)

  • You-Yeon Won

    (Purdue University
    Purdue University Institute for Cancer Research)

  • Qing Deng

    (Purdue University Institute for Cancer Research
    Purdue University)

  • Xiaojun Lance Lian

    (The Pennsylvania State University
    The Pennsylvania State University
    The Pennsylvania State University)

  • Xiaoguang Wang

    (The Ohio State University
    The Ohio State University)

  • Omolola Eniola-Adefeso

    (University of Michigan)

  • Xiaoping Bao

    (Purdue University
    Purdue University Institute for Cancer Research)

Abstract

Glioblastoma (GBM) is one of the most aggressive and lethal solid tumors in human. While efficacious therapeutics, such as emerging chimeric antigen receptor (CAR)-T cells and chemotherapeutics, have been developed to treat various cancers, their effectiveness in GBM treatment has been hindered largely by the blood-brain barrier and blood-brain-tumor barriers. Human neutrophils effectively cross physiological barriers and display effector immunity against pathogens but the short lifespan and resistance to genome editing of primary neutrophils have limited their broad application in immunotherapy. Here we genetically engineer human pluripotent stem cells with CRISPR/Cas9-mediated gene knock-in to express various anti-GBM CAR constructs with T-specific CD3ζ or neutrophil-specific γ-signaling domains. CAR-neutrophils with the best anti-tumor activity are produced to specifically and noninvasively deliver and release tumor microenvironment-responsive nanodrugs to target GBM without the need to induce additional inflammation at the tumor sites. This combinatory chemo-immunotherapy exhibits superior and specific anti-GBM activities, reduces off-target drug delivery and prolongs lifespan in female tumor-bearing mice. Together, this biomimetic CAR-neutrophil drug delivery system is a safe, potent and versatile platform for treating GBM and possibly other devastating diseases.

Suggested Citation

  • Yun Chang & Xuechao Cai & Ramizah Syahirah & Yuxing Yao & Yang Xu & Gyuhyung Jin & Vijesh J. Bhute & Sandra Torregrosa-Allen & Bennett D. Elzey & You-Yeon Won & Qing Deng & Xiaojun Lance Lian & Xiaogu, 2023. "CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
  • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37872-4
    DOI: 10.1038/s41467-023-37872-4
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-37872-4
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-023-37872-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Giulia Agliardi & Anna Rita Liuzzi & Alastair Hotblack & Donatella Feo & Nicolás Núñez & Cassandra L. Stowe & Ekaterina Friebel & Francesco Nannini & Lukas Rindlisbacher & Thomas A. Roberts & Rajiv Ra, 2021. "Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
    2. Patricia P. Yee & Yiju Wei & Soo-Yeon Kim & Tong Lu & Stephen Y. Chih & Cynthia Lawson & Miaolu Tang & Zhijun Liu & Benjamin Anderson & Krishnamoorthy Thamburaj & Megan M. Young & Dawit G. Aregawi & M, 2020. "Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression," Nature Communications, Nature, vol. 11(1), pages 1-22, December.
    3. Asuka Morizane & Tetsuhiro Kikuchi & Takuya Hayashi & Hiroshi Mizuma & Sayuki Takara & Hisashi Doi & Aya Mawatari & Matthew F. Glasser & Takashi Shiina & Hirohito Ishigaki & Yasushi Itoh & Keisuke Oki, 2017. "MHC matching improves engraftment of iPSC-derived neurons in non-human primates," Nature Communications, Nature, vol. 8(1), pages 1-12, December.
    4. Haig Aghajanian & Toru Kimura & Joel G. Rurik & Aidan S. Hancock & Michael S. Leibowitz & Li Li & John Scholler & James Monslow & Albert Lo & Wei Han & Tao Wang & Kenneth Bedi & Michael P. Morley & Ri, 2019. "Targeting cardiac fibrosis with engineered T cells," Nature, Nature, vol. 573(7774), pages 430-433, September.
    5. Erik Jung & Matthias Osswald & Miriam Ratliff & Helin Dogan & Ruifan Xie & Sophie Weil & Dirk C. Hoffmann & Felix T. Kurz & Tobias Kessler & Sabine Heiland & Andreas Deimling & Felix Sahm & Wolfgang W, 2021. "Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma," Nature Communications, Nature, vol. 12(1), pages 1-16, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Zebin Xiao & Leslie Todd & Li Huang & Estela Noguera-Ortega & Zhen Lu & Lili Huang & Meghan Kopp & Yue Li & Nimisha Pattada & Wenqun Zhong & Wei Guo & John Scholler & Maria Liousia & Charles-Antoine A, 2023. "Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors," Nature Communications, Nature, vol. 14(1), pages 1-21, December.
    2. Lindo, Jason M. & Pineda-Torres, Mayra, 2021. "New Evidence on the Effects of Mandatory Waiting Periods for Abortion," Journal of Health Economics, Elsevier, vol. 80(C).
    3. Toshiyuki Ko & Seitaro Nomura & Shintaro Yamada & Kanna Fujita & Takanori Fujita & Masahiro Satoh & Chio Oka & Manami Katoh & Masamichi Ito & Mikako Katagiri & Tatsuro Sassa & Bo Zhang & Satoshi Hatsu, 2022. "Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-β-IGFBP7 axis," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    4. Marc Cicero Schubert & Stella Judith Soyka & Amr Tamimi & Emanuel Maus & Julian Schroers & Niklas Wißmann & Ekin Reyhan & Svenja Kristin Tetzlaff & Yvonne Yang & Robert Denninger & Robin Peretzke & Ca, 2024. "Deep intravital brain tumor imaging enabled by tailored three-photon microscopy and analysis," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
    5. Kengo Abe & Akihiro Yamashita & Miho Morioka & Nanao Horike & Yoshiaki Takei & Saeko Koyamatsu & Keisuke Okita & Shuichi Matsuda & Noriyuki Tsumaki, 2023. "Engraftment of allogeneic iPS cell-derived cartilage organoid in a primate model of articular cartilage defect," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    6. Ling Hai & Dirk C. Hoffmann & Robin J. Wagener & Daniel D. Azorin & David Hausmann & Ruifan Xie & Magnus-Carsten Huppertz & Julien Hiblot & Philipp Sievers & Sophie Heuer & Jakob Ito & Gina Cebulla & , 2024. "A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1," Nature Communications, Nature, vol. 15(1), pages 1-29, December.
    7. Songlei Zhou & Yukun Huang & Yu Chen & Yipu Liu & Laozhi Xie & Yang You & Shiqiang Tong & Jianpei Xu & Gan Jiang & Qingxiang Song & Ni Mei & Fenfen Ma & Xiaoling Gao & Hongzhuan Chen & Jun Chen, 2023. "Reprogramming systemic and local immune function to empower immunotherapy against glioblastoma," Nature Communications, Nature, vol. 14(1), pages 1-20, December.
    8. Zhihong Chen & Nishant Soni & Gonzalo Pinero & Bruno Giotti & Devon J. Eddins & Katherine E. Lindblad & James L. Ross & Montserrat Puigdelloses Vallcorba & Tanvi Joshi & Angelo Angione & Wes Thomason , 2023. "Monocyte depletion enhances neutrophil influx and proneural to mesenchymal transition in glioblastoma," Nature Communications, Nature, vol. 14(1), pages 1-24, December.
    9. Lata Adnani & Jordan Kassouf & Brian Meehan & Cristiana Spinelli & Nadim Tawil & Ichiro Nakano & Janusz Rak, 2022. "Angiocrine extracellular vesicles impose mesenchymal reprogramming upon proneural glioma stem cells," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    10. Cristiana Spinelli & Lata Adnani & Brian Meehan & Laura Montermini & Sidong Huang & Minjun Kim & Tamiko Nishimura & Sidney E. Croul & Ichiro Nakano & Yasser Riazalhosseini & Janusz Rak, 2024. "Mesenchymal glioma stem cells trigger vasectasia—distinct neovascularization process stimulated by extracellular vesicles carrying EGFR," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
    11. Verena Turco & Kira Pfleiderer & Jessica Hunger & Natalie K. Horvat & Kianush Karimian-Jazi & Katharina Schregel & Manuel Fischer & Gianluca Brugnara & Kristine Jähne & Volker Sturm & Yannik Streibel , 2023. "T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles," Nature Communications, Nature, vol. 14(1), pages 1-15, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-37872-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.